The North America Chin Augmentation Market would witness market growth of 5.1% CAGR during the forecast period (2023-2030).
Chin augmentation is a cosmetic procedure that utilizes alloplastic implants, bone advancements, or facial fillers to increase the jaw size. Several factors, such as changing beauty standards in developing nations, growing financial accessibility to aesthetic treatments, increasing regulatory sanction for dermal fillers, and growing cosmetic demand from an aging population, are anticipated to drive market expansion.
The American Society of Plastic Surgeons reports that 25 percent of chin augmentation procedures were performed on patients aged 55 to 69 in 2020. Increasing financing options for cosmetic surgery benefit the market. Financing alternatives make chin augmentation and other cosmetic procedures more accessible to prospective patients, promoting market expansion. Companies such as Prosper Healthcare Lending offer financing options for cosmetic procedures.
Moreover, the company has invested over $5 billion in cosmetic procedures. AbbVie and PatientFi expanded their partnership in April 2022 when PatientFi introduced financing options for AbbVie's aesthetic products, including Juvederm, BOTOX, and others. Such marketing agreements are expected to enhance the market during the forecast period.
The adoption of chin augmentation procedures in North America has been steadily increasing over the years. This trend can be attributed to various factors, including changing beauty standards, increased awareness of cosmetic procedures, advancements in techniques, and a growing acceptance of aesthetic enhancements. Evolving beauty ideals and a greater emphasis on facial harmony and balance have led many individuals to consider chin augmentation to enhance their appearance. As the population in North America ages, more people are seeking cosmetic procedures to address signs of aging, including changes in the chin and jawline. Chin augmentation procedures are not limited to a specific gender. Both men and women in North America seek these treatments to achieve their desired facial aesthetics.
The US market dominated the North America Chin Augmentation Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $447.4 million by 2030. The Canada market is experiencing a CAGR of 7.5% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 6.5% during (2023 - 2030).
Based on Gender, the market is segmented into Female, and Male. Based on Procedure, the market is segmented into Surgical (Chin Implant, and Bone Advancement), and Non-Surgical. Based on End-use, the market is segmented into Cosmetic Surgery Centers, Hospitals, and MedSpas. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Chin Augmentation Market is Predict to reach $1.8 Billion by 2030, at a CAGR of 6.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include New York Plastic Surgical Group, PC (Long Island Plastic Surgical Group, PC), Westlake Dermatology & Cosmetic Surgery, Nazarian Plastic Surgery, Ruby Plastic Surgery, Cadogan Clinic, UK Aesthetic, Marroquin & Sandoval Plastic Surgery, UK HealthCare Aesthetics Center, Advanced Cosmetic Surgery, Orange County Facial Plastic Surgery
By Gender
By Procedure
By End-use
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
